======= FBXL20 ======= == Gene Information == * **Official Symbol**: FBXL20 * **Official Name**: F-box and leucine rich repeat protein 20 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84961|84961]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96IG2|Q96IG2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FBXL20&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FBXL20|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609086|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Substrate-recognition component of the SCF (SKP1-CUL1-F- box protein)-type E3 ubiquitin ligase complex. Role in neural transmission (By similarity). {ECO:0000250}. |F-box| |F-box-like| |regulation of protein catabolic process at presynapse, modulating synaptic transmission| |presynaptic modulation of chemical synaptic transmission| |behavioral fear response| |behavioral defense response| |fear response| |SCF ubiquitin ligase complex| |multicellular organismal response to stress| |regulation of synaptic vesicle exocytosis| |Schaffer collateral - CA1 synapse| |SCF-dependent proteasomal ubiquitin-dependent protein catabolic process| |presynapse| |regulation of neurotransmitter secretion| |regulation of synaptic vesicle cycle| |regulation of neurotransmitter transport| |regulation of regulated secretory pathway| |regulation of exocytosis| |ubiquitin-protein transferase activity| |protein polyubiquitination| |proteasome-mediated ubiquitin-dependent protein catabolic process| |glutamatergic synapse| |proteasomal protein catabolic process| |regulation of neurotransmitter levels| |post-translational protein modification| |regulation of protein catabolic process| |modulation of chemical synaptic transmission| |regulation of trans-synaptic signaling| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |regulation of vesicle-mediated transport| |behavior| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |protein catabolic process| |protein ubiquitination| |regulation of secretion by cell| |protein modification by small protein conjugation| |regulation of secretion| |cellular macromolecule catabolic process| |regulation of cellular localization| |protein modification by small protein conjugation or removal| |regulation of catabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |proteolysis| |defense response| |organic substance catabolic process| |cellular catabolic process| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp135|MS023 7μM R03 exp135]]|1.7| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.7| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|1.71| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|1.8| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.81| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|1.81| |[[:results:exp264|Arsenate 40μM R06 exp264]]|1.86| |[[:results:exp292|Menadione 5μM R06 exp292]]|1.93| |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|1.95| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.98| |[[:results:exp34|Rotenone 20μM R00 exp34]]|1.99| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2| |[[:results:exp492|iCRT14 30μM R08 exp492]]|2.04| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.04| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|2.1| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|2.16| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|2.17| |[[:results:exp485|GSK626616 14μM R08 exp485]]|2.25| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|2.25| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|2.54| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|2.82| |[[:results:exp134|MS023 2μM R03 exp134]]|2.89| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|3.07| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|3.67| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14307 * **Expression level (log2 read counts)**: 5.36 {{:chemogenomics:nalm6 dist.png?nolink |}}